Experimental Modeling of Proliferative Vitreoretinopathy. An Experimental Morphological Study
| LEADER | caa a22 4500 | ||
|---|---|---|---|
| 001 | 60553490X | ||
| 003 | CHVBK | ||
| 005 | 20210128100845.0 | ||
| 007 | cr unu---uuuuu | ||
| 008 | 210128e20150501xx s 000 0 eng | ||
| 024 | 7 | 0 | |a 10.1007/s10517-015-2900-2 |2 doi |
| 035 | |a (NATIONALLICENCE)springer-10.1007/s10517-015-2900-2 | ||
| 245 | 0 | 0 | |a Experimental Modeling of Proliferative Vitreoretinopathy. An Experimental Morphological Study |h [Elektronische Daten] |c [I. Khoroshilova-Maslova, N. Leparskaya, M. Nabieva, L. Andreeva] |
| 520 | 3 | |a A model of proliferative vitreoretinopathy induced by simultaneous intravitreal injection of recombinant IL-1β and platelet concentrate is created and its main morphological manifestations are studied on Chinchilla rabbits. The model reflects pathogenesis of proliferative vitreoretinopathy: epiretinal membrane with the formation of retinal plication, traction detachment of the retina; moderate inflammatory reaction in the uveal tract, in the optic nerve infundibulum, in the vitreous body; intact structural elements of the retina, dissociation of the retinal pigmented epithelium cells with their subsequent migration. The model is adequate to the clinical picture of proliferative vitreoretinopathy in humans, which recommends it for experimental studies of the efficiency of drug therapy and prevention of this disease. | |
| 540 | |a Springer Science+Business Media New York, 2015 | ||
| 690 | 7 | |a proliferative vitreoretinopathy |2 nationallicence | |
| 690 | 7 | |a interleukine-1β |2 nationallicence | |
| 690 | 7 | |a platelet concentrate |2 nationallicence | |
| 690 | 7 | |a epiretinal membrane |2 nationallicence | |
| 700 | 1 | |a Khoroshilova-Maslova |D I. |u Helmholtz Moscow Research Institute of Ocular Diseases, Ministry of Health of the Russian Federation, Moscow, Russia |4 aut | |
| 700 | 1 | |a Leparskaya |D N. |u Helmholtz Moscow Research Institute of Ocular Diseases, Ministry of Health of the Russian Federation, Moscow, Russia |4 aut | |
| 700 | 1 | |a Nabieva |D M. |u Helmholtz Moscow Research Institute of Ocular Diseases, Ministry of Health of the Russian Federation, Moscow, Russia |4 aut | |
| 700 | 1 | |a Andreeva |D L. |u Helmholtz Moscow Research Institute of Ocular Diseases, Ministry of Health of the Russian Federation, Moscow, Russia |4 aut | |
| 773 | 0 | |t Bulletin of Experimental Biology and Medicine |d Springer US; http://www.springer-ny.com |g 159/1(2015-05-01), 100-102 |x 0007-4888 |q 159:1<100 |1 2015 |2 159 |o 10517 | |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s10517-015-2900-2 |q text/html |z Onlinezugriff via DOI |
| 898 | |a BK010053 |b XK010053 |c XK010000 | ||
| 900 | 7 | |a Metadata rights reserved |b Springer special CC-BY-NC licence |2 nationallicence | |
| 908 | |D 1 |a research-article |2 jats | ||
| 949 | |B NATIONALLICENCE |F NATIONALLICENCE |b NL-springer | ||
| 950 | |B NATIONALLICENCE |P 856 |E 40 |u https://doi.org/10.1007/s10517-015-2900-2 |q text/html |z Onlinezugriff via DOI | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Khoroshilova-Maslova |D I. |u Helmholtz Moscow Research Institute of Ocular Diseases, Ministry of Health of the Russian Federation, Moscow, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Leparskaya |D N. |u Helmholtz Moscow Research Institute of Ocular Diseases, Ministry of Health of the Russian Federation, Moscow, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Nabieva |D M. |u Helmholtz Moscow Research Institute of Ocular Diseases, Ministry of Health of the Russian Federation, Moscow, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Andreeva |D L. |u Helmholtz Moscow Research Institute of Ocular Diseases, Ministry of Health of the Russian Federation, Moscow, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 773 |E 0- |t Bulletin of Experimental Biology and Medicine |d Springer US; http://www.springer-ny.com |g 159/1(2015-05-01), 100-102 |x 0007-4888 |q 159:1<100 |1 2015 |2 159 |o 10517 | ||